A Multicenter Extension Study of Taliglucerase Alfa in Pediatric Subjects With Gaucher Disease
Clinical trial NCT01411228 · COMPLETED
Trial details
- NCT number
- NCT01411228
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2014-07-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.